language_icon
EN
HI

Nephrocare Health Services Share price

NEPHROPLUS

528.6

0.30 (0.06%)
NSE
BSE
Last updated on 2 Apr, 2026 | 15:40 IST
Today's High

533.00

Today's Low

506.20

52 Week Low

446.00

52 Week High

616.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Nephrocare Health Services Chart

Nephrocare Health Services Share Key Metrics

Volume
36825.00
Market Cap
5304.01 CR
LTQ@LTP
40@528.60
ATP
519.35
Var Margin
13.56 %
Circuit Range
422.65-633.95
Delivery %
59.91 %
Value
1.91 CR
ASM/GSM
No
Market Lot
1

Summary

At 2 Apr, 2026 | 15:40, Nephrocare Health Services share price stands at ₹528.6, showing a 0.30% 0.06 for the day. The stock’s intraday movement has stayed between ₹506.20 and ₹533.00, while on a 52-week basis it has fluctuated from ₹446.00 to ₹616.00.
In terms of trading activity, Nephrocare Health Services has recorded a volume of 36825 shares, with a market capitalisation of ₹100340717. The stock’s Average Traded Price (ATP) stands at ₹51935, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 40,52860. The stock operates within a circuit range of ₹422.65-633.95, with a Value of ₹1.91 CR. The Delivery Percentage for the day is 59.91%. Additionally, Nephrocare Health Services currently falls under the No framework, and trades with a market lot size of 1.

Nephrocare Health Services Fundamentals

View More
P/E Ratio

79.13

P/B Ratio

5.47

Div. Yield

0

Sector P/E

47.88

Sector P/B

-16.66

Sec. Div. Yield

2.69

Nephrocare Health Services Resistance and Support

Pivot 530.42

Resistance

First Resistance

539.84

Second Resistance

551.37

Third Resistance

560.79

Support

First Support

518.89

Second Support

509.47

Third Support

497.94

Nephrocare Health Services Futures & Options

Data Not Found

Nephrocare Health Services Shareholding Pattern

View More
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

63.85%

Mutual Fund

3.44%

Insurance

1.05%

Foreign Institutional Investors

3.59%

Domestic Institutional Investors

4.19%

Retail

23.88%

Others

0%

Total Promoters
SEP '25
0%
DEC '25
63.85%

Nephrocare Health Services Corporate Actions

DateAgenda
2026-02-10Quarterly Results

Nephrocare Health Services News

Nephrocare Health Services Ltd - 544647 - Announcement Under Regulation 30 (LODR)- Disclosure Of Litigation Filed By The Company

Nephrocare Health Services filed a writ petition in the Hon'ble High Court of Jammu & Kashmir and Ladakh challenging a ₹2.51 crore GST demand from authorities. The company asserts the demand is not tenable and anticipates no material financial impact from the legal challenge.
Apr 02 2026 17:04:00

Nephrocare Health Services Limited

Nephrocare Health Services will attend the Dam Capital Conference for analyst and institutional investor meetings on March 23, 2026. The meetings will include group and one-on-one interactions in Mumbai, starting at 10:00 AM IST.
Mar 16 2026 19:03:00
Read More

About Nephrocare Health Services

NSE : 760346  
BSE : 544647  
ISIN : INE428V01029  

Our Company was incorporated as “Nephrocare Health Services Private Limited” a private limited company under the Companies Act 1956 at Hyderabad with a certificate of incorporation issued by the Assistant Registrar of Companies Andhra Pradesh (“RoC Andhra Pradesh”) on December 18 2009. Pursuant to resolutions dated April 11 2025 and June 2 2025 passed by our Board and Shareholders respectively our Company was converted into a public limited company and consequently the name of our Company was changed to “Nephrocare Health Services Limited” with a fresh certificate of incorporation dated June 18 2025 issued by the Registrar of Companies Central Registration Centre.Major events and milestones:2010- Launched our first standalone clinic in Banjara Hills Hyderabad India.2012- Launched our first Public Private Partnership (“PPP”) clinic in Sananth Nagar Hyderabad India2015- Launched 50th dialysis clinic and crossed 10000+ treatments per month2018- Acquired DaVita Care (India) Private Limited the Indian arm of DaVita Care Pte Ltd.2020- Launched operations in Philippines by acquiring Royal Care Dialysis Center Inc2022- Launched operations in Uzbekistan after the award of PPP tender.2024- Acquired a network of six clinics in Philippines pursuant to the acquisition of Renal Therapy Solutions Inc.2025- Acquired and a chain of seven clinics (AIZ Hemodialysis Center Inc. Bioregen Hemo Center Inc. Carmona Dialysis System Inc. Infini Care Health Systems Inc. and Kolff Dialysis Inc.)- Crossed 500+ clinic globally

Read More

Nephrocare Health Services Management

NamePosition
Mr. Vikram Vuppala Chairman & Managing Director
Mr. Vishal Vijay Gupta Non Exe. & Nominee Director
View More

Nephrocare Health Services FAQs

The Buying Price of Nephrocare Health Services share is 528.6 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Nephrocare Health Services stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Nephrocare Health Services, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Nephrocare Health Services shares is 79.13. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Nephrocare Health Services shares is 5.47. Useful to assess the stock's value relative to its book value.

To assess Nephrocare Health Services’s valuation compare Sector P/E, P/B which are 47.88 & -16.66 with sector averages, along with growth rates and financial metrics.

The Market Cap of Nephrocare Health Services is 5304.01 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Nephrocare Health Services share price is 616.00 & 446.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Nephrocare Health Services belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost